Cellular Vehicles

Cellular Vehicles is building the infrastructure for final formulation and last-mile delivery of advanced therapies. The company has developed the Odyssey System, a closed, automated, small-footprint process automation platform that leverages microfluidics, robotics, and AI to replace the specialized staff, lab, and fragmented equipment that advanced therapy delivery currently requires. The Odyssey System simplifies last-mile cell and gene therapy handling, preparation, and administration into a single automated instrument. Cellular Vehicles partners with biopharma companies, CDMOs, and academic medical centers to co-develop custom software protocols and single-use kits for applications including solid tumor CAR T-cells, neurodegenerative diseases, regenerative medicine, and tissue engineering. The company's mission is to accelerate the advent of curative therapies and ensure all patients have access.